Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Therapeutic Drug Monitoring|July 2, 2004
Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau"Finn BengtssonTherapeutic Drug Monitoring|March 27, 2003
Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997Margareta Reis, Jöns Lundmark, Finn BengtssonPharmacology & Toxicology|October 31, 2002
Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in ratsFredrik C Kugelberg, Gustav Apelqvist, Finn BengtssonJournal of Analytical Toxicology|February 26, 2009
Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19Björn Carlsson, Anita Holmgren, Johan Ahlner, et al.Therapeutic Drug Monitoring|July 27, 2002
Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical settingMargareta Reis, Jöns Lundmark, Henrik Björk, et al.Journal of Chromatography. A|March 9, 2002
Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatographyDaniel Ohman, Björn Norlander, Curt Peterson, et al.Chirality|July 4, 2003
Stereoselective single-dose kinetics of citalopram and its metabolites in ratsFredrik C Kugelberg, Björn Carlsson, Johan Ahlner, et al.Therapeutic Drug Monitoring|November 29, 2007
Therapeutic drug monitoring of escitalopram in an outpatient settingMargareta Reis, Maria D Chermá, Björn Carlsson, et al.Therapeutic Drug Monitoring|March 27, 2003
Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetineDaniel Ohman, Maria D Cherma, Björn Norlander, et al.Basic & Clinical Pharmacology & Toxicology|September 1, 2005
Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxineFredrik C Kugelberg, Gustav Apelqvist, Cecilia Wikell, et al.Pageof 4